Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Author response: Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement.

Russell JA.

Neurology. 2019 Nov 19;93(21):948. doi: 10.1212/WNL.0000000000008532. No abstract available.

PMID:
31740516
2.

Cost vs care.

Russell JA, Dorsey ER.

Neurology. 2019 Dec 3;93(23):985-986. doi: 10.1212/WNL.0000000000008568. Epub 2019 Oct 31. No abstract available.

PMID:
31672713
3.

Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During Sepsis.

Shimada T, Topchiy E, Leung AKK, Kong HJ, Genga KR, Boyd JH, Russell JA, Oda S, Nakada TA, Hirasawa H, Walley KR.

Crit Care Med. 2019 Oct 23. doi: 10.1097/CCM.0000000000004064. [Epub ahead of print]

PMID:
31651422
4.

Vasopressor therapy in critically ill patients with shock.

Russell JA.

Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23. Review.

PMID:
31646370
5.

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.

Laterre PF, Berry SM, Blemings A, Carlsen JE, François B, Graves T, Jacobsen K, Lewis RJ, Opal SM, Perner A, Pickkers P, Russell JA, Windeløv NA, Yealy DM, Asfar P, Bestle MH, Muller G, Bruel C, Brulé N, Decruyenaere J, Dive AM, Dugernier T, Krell K, Lefrant JY, Megarbane B, Mercier E, Mira JP, Quenot JP, Rasmussen BS, Thorsen-Meyer HC, Vander Laenen M, Vang ML, Vignon P, Vinatier I, Wichmann S, Wittebole X, Kjølbye AL, Angus DC; SEPSIS-ACT Investigators.

JAMA. 2019 Oct 2. doi: 10.1001/jama.2019.14607. [Epub ahead of print] Erratum in: JAMA. 2019 Oct 15;:.

PMID:
31577035
6.

Toward Increased Understanding of the Steroid Controversy in Septic Shock.

Russell JA, Sevransky J.

Crit Care Med. 2019 Dec;47(12):1677-1679. doi: 10.1097/CCM.0000000000004038. No abstract available.

PMID:
31567353
7.

Reader response: Michael H. Brooke, MB, BCh (1934-2018).

Russell JA.

Neurology. 2019 Sep 3;93(10):463. doi: 10.1212/WNL.0000000000008069. No abstract available.

PMID:
31477614
8.

Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients.

Leung AKK, Genga KR, Topchiy E, Cirstea M, Shimada T, Fjell C, Russell JA, Boyd JH, Walley KR.

Sci Rep. 2019 Jul 22;9(1):10588. doi: 10.1038/s41598-019-46745-0.

9.

Terlipressin or norepinephrine in septic shock: do we have the answer?

Williams MD, Russell JA.

J Thorac Dis. 2019 May;11(Suppl 9):S1270-S1273. doi: 10.21037/jtd.2019.05.07. No abstract available.

10.

The Specific Organism: Not Bacterial Gram Type: Drives the Inflammatory Response in Septic Shock.

Linder A, Fjell CD, Inghammar M, Hsu J, Walley KR, Boyd JH, Russell JA.

J Innate Immun. 2019 Jun 26:1-9. doi: 10.1159/000500418. [Epub ahead of print]

11.

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.

Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettilä V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D; SCARLET Trial Group.

JAMA. 2019 May 28;321(20):1993-2002. doi: 10.1001/jama.2019.5358.

12.

Once or Twice Daily Screening for Weaning the Critically Ill-Have We Set Our Sights Too Low?

Genga KR, Boyd J, Russell JA.

Crit Care Med. 2019 Jun;47(6):874-875. doi: 10.1097/CCM.0000000000003737. No abstract available.

PMID:
31095020
13.

Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.

Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, Mason AJ, Ashby D, Gordon AC.

Intensive Care Med. 2019 Jun;45(6):844-855. doi: 10.1007/s00134-019-05620-2. Epub 2019 May 6. Review.

PMID:
31062052
14.

The authors reply.

Fisher J, Linder A, Caironi P, Russell JA.

Crit Care Med. 2019 Apr;47(4):e378-e379. doi: 10.1097/CCM.0000000000003683. No abstract available.

PMID:
30882444
15.

Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock.

Russell JA, Gordon AC, Walley KR.

Am J Respir Crit Care Med. 2019 May 1;199(9):1049-1051. doi: 10.1164/rccm.201901-0083ED. No abstract available.

16.

Genetic Polymorphisms in Sepsis and Cardiovascular Disease: Do Similar Risk Genes Suggest Similar Drug Targets?

Nakada TA, Takahashi W, Nakada E, Shimada T, Russell JA, Walley KR.

Chest. 2019 Jun;155(6):1260-1271. doi: 10.1016/j.chest.2019.01.003. Epub 2019 Jan 17. Review.

PMID:
30660782
17.

Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement.

Russell JA, Epstein LG, Greer DM, Kirschen M, Rubin MA, Lewis A; Brain Death Working Group.

Neurology. 2019 Jan 2. pii: 10.1212/WNL.0000000000006750. doi: 10.1212/WNL.0000000000006750. [Epub ahead of print] Erratum in: Neurology. 2019 Feb 5;92(6):304.

PMID:
30602465
18.

Treatment with a polymyxin B filter to capture endotoxin in sepsis patients: is there a signal for therapeutic efficacy?

Pickkers P, Russell JA.

Intensive Care Med. 2019 Feb;45(2):282-283. doi: 10.1007/s00134-018-5481-5. Epub 2018 Dec 3. No abstract available.

PMID:
30511248
19.

Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital.

Russell JA, Wellman H, Walley KR.

J Intensive Care. 2018 Nov 16;6:73. doi: 10.1186/s40560-018-0344-2. eCollection 2018.

20.

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.

Genga KR, Lo C, Cirstea MS, Leitao Filho FS, Walley KR, Russell JA, Linder A, Francis GA, Boyd JH.

EBioMedicine. 2018 Dec;38:257-264. doi: 10.1016/j.ebiom.2018.11.032. Epub 2018 Nov 23.

Supplemental Content

Loading ...
Support Center